Use of intraperitoneal interferon -2b therapy after conservative surgery for endometriosis and postoperative medical treatment with depot gonadotropin-releasing hormone analog: a randomized clinical trial

Author： Acien P.   Quereda F.   Campos A.   Gomez-Torres M.-J.   Velasco I.   Gutierrez M.  

Publisher： Elsevier

ISSN： 0015-0282

Source： Fertility and Sterility, Vol.78, Iss.4, 2002-10, pp. : 705-711

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up

By Pierce S.J.   Gazvani M.R.   Farquharson R.G.  

Fertility and Sterility, Vol. 74, Iss. 5, 2000-11 ,pp. : 964-968

Elsevier

Access to resources Recommend Favorite

Gonadotropin-releasing hormone agonist plus ''add-back'' hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial

By Franke H.R.   van de Weijer P.H.M.   Pennings T.M.M.   van der Mooren M.J.  

Fertility and Sterility, Vol. 74, Iss. 3, 2000-09 ,pp. : 534-539

Elsevier

Access to resources Recommend Favorite

Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis

By Rickes D.   Nickel I.   Kropf S.   Kleinstein J.  

Fertility and Sterility, Vol. 78, Iss. 4, 2002-10 ,pp. : 757-762

Elsevier

Access to resources Recommend Favorite

The comparison of gonadotropin-releasing hormone agonist therapy and intraperitoneal Ringer's lactate solution in prevention of postoperative adhesion formation in rat models

By Canbaz M.A.   Ustun C.   Kocak I.   Yanik F.F.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 82, Iss. 2, 1999-02 ,pp. : 219-222

Elsevier

Access to resources Recommend Favorite

Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (''draw-back'' therapy)

By Tahara M.   Matsuoka T.   Yokoi T.   Tasaka K.   Kurachi H.   Murata Y.  

Fertility and Sterility, Vol. 73, Iss. 4, 2000-04 ,pp. : 799-804

Elsevier

Access to resources Recommend Favorite